Expression of tumor necrosis factor receptor superfamily members by lung T lymphocytes in interstitial lung disease

被引:61
|
作者
Agostini, C [1 ]
Zambello, R [1 ]
Sancetta, R [1 ]
Cerutti, A [1 ]
Milani, A [1 ]
Tassinari, C [1 ]
Facco, M [1 ]
Cipriani, A [1 ]
Trentin, L [1 ]
Semenzato, G [1 ]
机构
[1] UNIV PADUA,PADUA HOSP,DEPT CLIN & EXPTL MED,DIV PNEUMOPHTHISIOL,SCH MED,PADUA,ITALY
关键词
D O I
10.1164/ajrccm.153.4.8616567
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Recently, a novel receptor superfamily has been identified whose members interact with a parallel family of ligands showing homology to tumor necrosis factor (TNF). To investigate the role of these receptor structures in the pulmonary environment, we evaluated the expression of some members of the TNF-receptor (CD27, CD30, CD40, CD95/Fas, CD120a, and CD120b) and TNF-ligand (CD40L, CD70/CD27L, CD30L, and mTNF alpha) superfamilies by bronchoalveolar lavage (BAL) T cells recovered from healthy subjects and patients with interstitial lung disease (ILD). Lung T lymphocytes recovered from control subjects showed a slight expression of CD27 but did not bear CD30, CD40, CD120a, or CD120b antigens. CD27 expression was restricted to normal CD4(+) cells. Fas antigen (CD95), which is involved in activation-driven T-cell suicide, and the ligand for CD27 (CD70) were weakly expressed by normal BAL T-cell subpopulations. In patients with sarcoidosis, the majority of pulmonary T lymphocytes were CD4(+) cells that expressed low levels of CD27 antigen and an upregulation of CD95 and CD70 molecules. When we characterized lymphocytes accumulating in the lung of patients with HIV infection and hypersensitivity pneumonitis, we demonstrated that T cells accounting for the CD8 alveolitis bore TN F-receptor type 2 (CD120b) at high density and were CD70(+) while CD40L, CD30L, or mTNF-alpha expression were not found. The discrete surface expression of the TNF-receptors and TNF-ligands on alveolar T-cell subsets suggests that these molecules play a role in the immune regulatory mechanisms that ultimately lead to the alveolitis in the pulmonary microenvironment of interstitial lung disease.
引用
收藏
页码:1359 / 1367
页数:9
相关论文
共 50 条
  • [41] Differential Roles of Tumor Necrosis Factor Ligand Superfamily Members as Biomarkers in Pancreatic Cancer
    Pombeiro, Ines
    Loosen, Sven H.
    Roy, Sanchari
    Schueller, Florian
    Niewenhuisen, Lukas
    Luedde, Mark
    Vucur, Mihael
    Tacke, Frank
    Binneboesel, Marcel
    Schoening, Wenzel
    Trautwein, Christian
    Luedde, Tom
    Neumann, Ulf Peter
    Roderburg, Christoph
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (07):
  • [42] Tumor necrosis factor receptor family members in the immune system
    Gravestein, LA
    Borst, J
    SEMINARS IN IMMUNOLOGY, 1998, 10 (06) : 423 - 434
  • [43] Receptor Oligomerization and Its Relevance for Signaling by Receptors of the Tumor Necrosis Factor Receptor Superfamily
    Kucka, Kirstin
    Wajant, Harald
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 8
  • [44] Assembly of post-receptor signaling complexes for the tumor necrosis factor receptor superfamily
    Wu, H
    CELL SURFACE RECEPTORS, 2004, 68 : 225 - +
  • [45] EXPRESSION OF TUMOR-NECROSIS-FACTOR RECEPTORS IN HUMAN LUNG-CANCER CELLS AND NORMAL LUNG TISSUES
    SHIMOMOTO, H
    HASEGAWA, Y
    NOZAKI, Y
    TAKAGI, N
    SHIBAGAKI, T
    NAKAO, A
    SHIMOKATA, K
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1995, 13 (03) : 271 - 278
  • [46] Mortality in patients with rheumatoid arthritis-associated interstitial lung disease treated with an anti-tumor necrosis factor agent
    Koo, Bon San
    Hong, Seokchan.
    Kim, You Jae
    Kim, Yong-Gil
    Lee, Chang-Keun
    Yoo, Bin
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2015, 30 (01): : 104 - 109
  • [47] MORTALITY IN PATIENTS WITH RHEUMATOID ARTHRITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE TREATED WITH AN ANTI-TUMOR NECROSIS FACTOR AGENT
    Kim, Y. J.
    Koo, B. S.
    So, M. -W.
    Seo, W. J.
    Kim, Y-G.
    Lee, C-K.
    Yoo, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 444 - 444
  • [48] Expression of the thioredoxin system in interstitial lung disease
    Tiitto, L
    Kaarteenaho-Wiik, R
    Sormunen, R
    Holmgren, A
    Pääkkö, P
    Soini, Y
    Kinnula, VL
    JOURNAL OF PATHOLOGY, 2003, 201 (03): : 363 - 370
  • [49] EXPRESSION OF MEMBRANE-RECEPTOR FOR TUMOR-NECROSIS-FACTOR ON HUMAN BLOOD-LYMPHOCYTES
    ZOLA, H
    FLEGO, L
    WEEDON, H
    IMMUNOLOGY AND CELL BIOLOGY, 1993, 71 : 281 - 288
  • [50] Tumour necrosis factor inhibitor safety in rheumatoid arthritis-associated interstitial lung disease
    Mcdermott, Gregory C.
    Sparks, Jeffrey A.
    LANCET RHEUMATOLOGY, 2025, 7 (03): : e146 - e147